Announced Mon, 13 Jul · 19:28 IST

Filing of Reg 74(5) compliance certificate for Q1 FY27

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+13.7%1-day move

₹3.07

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+13.7-1.3-1.6-3.9-0.7-2.6————

Up moveDown movePending

AI summary

Transgene Biotek has submitted the Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent, Bigshare Services, for the quarter ended 30 June 2026. The certificate confirms that shares dematerialized and rematerialized through NSDL and CDSL between 1 April 2026 and 30 June 2026 were properly processed, listed on the stock exchange, and that certificates were mutilated and cancelled with the depository name substituted in the register of members within 15 days, as required by SEBI rules. This is a routine quarterly compliance submission with no material business disclosure.

Likely market impact

Routine quarterly regulatory compliance filing. No impact on operations, financials, or shareholders.